A rBCG strain expressing IFN-γ specifically increased MHC class I molecules in the bladder cancer cell line MB49 in vitro and could prolong survival in mice with murine orthotopic bladder cancer as compared to BCG treatment (17). The gene discussed is IFNG; the disease is urinary bladder cancer.